Article

Questions for Medicare in Meningitis Outbreak

Medicare is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The giant health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the Food and Drug Administration as safety risks. In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease.

Read the full story: http:/bit.ly/OQziq3

Source: The Associated Press

Related Videos
Casey Koch, PharmD, sitting for a video interview
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Related Content
Health insurance application | Image credit: Annap - stock.adobe.com
May 1st 2025

Aetna Members With ACA Plans Will Need New Coverage in 2026; CVS to Exit ACA Marketplace

Julia Bonavitacola
Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the Affordable Care Act (ACA) individual exchange business next year.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
The Senate | Image credit: MoiraM - stock.adobe.com
April 29th 2025

Trump’s First 100 Days: Workforce Cuts, Drug Pricing, and Medicaid Reform

Pearl Steinzor
Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Pharmaceuticals | Image credit: psphotography - stock.adobe.com
April 24th 2025

Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas

Pearl Steinzor
Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo